Midazolam oral solution
Sponsors
Boehringer Ingelheim, Brasilia University Hospital, Crinetics Pharmaceuticals Inc., Merck Sharp & Dohme LLC, Washington State University
Conditions
Ambulatory SurgeryAnxietyCircumcisionCluster SeizureDental CareDoseDrug InteractionEmergence Delirium
Early Phase 1
Phase 1
Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers
CompletedNCT02243553
Start: 2006-01-31Updated: 2014-09-18
Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers
CompletedNCT03276858
Start: 2017-09-22End: 2018-04-30Updated: 2018-08-29
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
CompletedNCT03311841
Start: 2018-03-01End: 2018-08-02Updated: 2020-01-09
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
CompletedNCT04008186
Start: 2019-06-14End: 2019-08-28Updated: 2025-05-30
Phase 2
Phase 3
Phase 4
Unknown Phase
Nebulized vs. Oral Midazolam Sedation in Pediatric Anesthesia: A Randomized Comparative Study
CompletedNCT04760041
Start: 2021-03-01End: 2021-08-10Updated: 2022-04-11
Effect of Testosterone Treatment on Drug Metabolism and Transport
Active, not recruitingNCT05116293
Start: 2021-05-01End: 2025-12-31Target: 12Updated: 2025-06-13
ED50 of Midazolam Oral Solution for Preoperative Hypnosis in Adults : An Up-and-Down Sequential Allocation Trial
CompletedNCT06018207
Start: 2023-09-05End: 2023-10-26Updated: 2025-08-06
Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
RecruitingNCT06056349
Start: 2023-05-01End: 2024-12-31Target: 150Updated: 2024-05-31
Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer
RecruitingNCT06407518
Start: 2024-07-24End: 2025-12-31Target: 280Updated: 2025-04-06
KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism
CompletedNCT06566794
Start: 2024-08-22End: 2025-01-10Updated: 2026-03-06